Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, indicating strong performance compared to the market [2]. Core Insights - The cosmetics and medical beauty sector has outperformed the market recently, with the Shenwan Beauty Care Index rising by 2.0% from January 16 to January 23, 2026, surpassing the Shenwan A Index by 0.8 percentage points [4][5]. - December 2025 saw a significant increase in social retail sales for cosmetics, reaching 38 billion yuan, with a growth rate of 8.8%, indicating robust demand even in the off-season. The overall growth rate for Q4 was 9.9%, significantly higher than the annual growth of 5.1% for 2025, driven by promotional events like Double 11 [10][17]. - The report anticipates continued high consumer demand in Q1 2026, supported by new product launches and regulatory approvals in the medical beauty sector [10]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has shown strong performance, with the Shenwan Cosmetics Index increasing by 2.6% and the Shenwan Personal Care Index rising by 4.2%, both outperforming the Shenwan A Index [4][5]. Key Company Reviews - Lin Qingxuan (2657HK) is highlighted as a benchmark in the high-end domestic skincare market, with revenue projected to grow from 690 million yuan in 2022 to 1.21 billion yuan in 2024, representing a CAGR of 32.7%. The company is expected to turn a profit of 187 million yuan in 2024, a 120% increase year-on-year [11][12]. - Langzi Co., Ltd. (002612.SZ) forecasts a net profit of 900 million to 1.05 billion yuan for 2025, reflecting a year-on-year growth of 245.25% to 302.80% [4]. - Qingsong Co., Ltd. (300132.SZ) anticipates a net profit of 130 million to 165 million yuan for 2025, with a growth rate of 137.73% to 201.74% [4]. Market Trends - The report notes that the high-end skincare market is expanding, with the market size expected to reach 218.5 billion yuan by 2029. The concept of "oil-based skincare" is becoming mainstream, driving growth in the facial oil segment, which is projected to grow at a CAGR of 42.8% from 2019 to 2024 [12][14]. - E-commerce channels are increasingly important, with Lin Qingxuan achieving a 65.4% online revenue share in H1 2025, leveraging platforms like Douyin and Tmall for growth [13]. Sales Data - In December 2025, the total retail sales of cosmetics reached 38 billion yuan, with a year-on-year growth of 8.8%. The overall retail sales for cosmetics in 2025 were 465.3 billion yuan, reflecting a 5.1% increase [17][21].

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 603193 | 润本股份 | 25.71 | 1.78% | 4.13万 | 1.06亿 | | 300888 | 稳健医疗 | 36.94 | 1.40% | 5.08万 | + 1.87亿 | | 001206 | 依依股份 | 28.47 | 1.10% | 2.18万 | 6178.24万 | | 605009 | 家用护理 | 32.39 | 0.90% | 1.62万 | 5232.99万 | | 002511 | 中顺洁桑 | 8.43 | 0.00% | 15.91万 | 1.34亿 | | 600249 | 两面针 | 6.10 | 0.00% | 9.92万 | 6038.24万 | | 301009 | 可靠股份 | 13.78 | -0.07% | 4.33万 | 5959.20万 | | 003006 | 百亚股份 | 22.28 | -0.13% | 5.36万 | 1.19亿 | | 001328 | 登康口腔 | ...

证券之星消息，1月21日个护用品板块较上一交易日上涨0.76%，延江股份领涨。当日上证指数报收于 4116.94，上涨0.08%。深证成指报收于14255.12，上涨0.7%。个护用品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300658 | 延江股份 | 20.90 | 7.73% | 59.56万 | 12.02亿 | | 603059 | 倍加洁 | 38.66 | 6.27% | 5.15万 | 1.95亿 | | 301108 | 洁雅股份 | 37.08 | 2.01% | 2.07万 | 7549.78万 | | 003006 | 百亚股份 | 22.96 | 2.00% | 13.31万 | 3.02亿 | | 301009 | 可靠股份 | 13.57 | 0.89% | 3.52万 | 4756.96万 | | 603193 | 润本股份 | 25.45 | 0.39% | 3.48万 | 8801.59万 | | 002511 | 中顺洁桑 | ...

Group 1 - The personal care products sector increased by 1.77% on January 20, with Yanjiang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 4113.65, down 0.01%, while the Shenzhen Component Index closed at 14155.63, down 0.97% [1] - Key stocks in the personal care sector showed varied performance, with Yanjiang Co., Ltd. closing at 19.40, up 9.11%, and Ziya Co., Ltd. at 22.51, up 4.16% [1] Group 2 - The personal care products sector experienced a net outflow of 47.99 million yuan from institutional investors, while retail investors saw a net inflow of 9.42 million yuan [2] - The trading volume for Yanjiang Co., Ltd. was 638,400 shares, with a total transaction value of 1.257 billion yuan [1] - The stock performance of major companies included a 2.51% increase for Beijia Co. and a 2.25% increase for Dengkang Oral Care [1][2] Group 3 - The net inflow from retail investors for the stock of Yiyi Co. was 400.92 million yuan, while the net outflow from institutional investors was 595.82 million yuan for Kela Co. [3] - The net inflow for Ziya Co. was 299.34 million yuan from retail investors, while it faced a net outflow of 1,407.33 million yuan from institutional investors [3] - The overall market sentiment showed mixed results, with some stocks like Yiyi Co. and Beijia Co. attracting retail interest despite institutional outflows [3]

Core Viewpoint - The personal care products sector experienced a 1.96% increase on January 19, with Yanjiang Co., Ltd. leading the gains, while the Shanghai Composite Index rose by 0.29% and the Shenzhen Component Index increased by 0.09% [1] Group 1: Market Performance - The closing price of Yanjiang Co., Ltd. was 17.78, reflecting a significant increase of 19.97% with a trading volume of 767,100 shares and a transaction value of 1.28 billion yuan [1] - Baiya Co., Ltd. closed at 21.61, up by 4.60%, with a trading volume of 130,400 shares and a transaction value of 283 million yuan [1] - Reliable Co., Ltd. saw a closing price of 13.46, increasing by 2.12% with a trading volume of 32,300 shares [1] Group 2: Fund Flow Analysis - The personal care products sector had a net outflow of 50.30 million yuan from institutional investors, while retail investors saw a net inflow of 17.49 million yuan [2] - The main funds showed a net inflow of 7.99 million yuan into Stable Medical, while the retail funds had a net outflow of 16.41 million yuan [3] - In contrast, Jingya Co., Ltd. experienced a net outflow of 3.24 million yuan from main funds, but retail funds showed a net inflow of 5.23 million yuan [3]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Views - The report highlights the competitive advantage of Qian Dama through its "community small store + daily clearance mechanism + warehouse and cold chain" model, which enhances supply stability and operational efficiency [3][24][35] - The report emphasizes the importance of emotional consumption themes and identifies high-quality companies in high-growth sectors, recommending specific companies across various segments [6][37] Summary by Sections Industry Overview - The retail and social service indices reported a decline of 1.47% and an increase of 1.53% respectively during the week of January 12-16, 2026 [5][13] - The internet e-commerce sector showed the highest growth, with a year-to-date increase of 11.18% [16][19] Company Highlights - Qian Dama has submitted its IPO application to the Hong Kong Stock Exchange, focusing on fresh food retail in the South China market, with a GMV of 9.8 billion yuan in 2024, significantly outperforming its competitors [24][25] - The company operates 2,983 stores, with 2,898 being franchise stores, contributing over 90% of its revenue [25][31] - The report recommends several companies based on their performance and market positioning, including: - Chaohongji, expected to achieve a net profit of 436-533 million yuan in 2025, driven by brand upgrades and channel expansion [39][43] - Meilitiantian Medical Health, projected to see a revenue increase of 28.2% in FY2025H1 [39] - Zhou Dafu, focusing on product structure optimization and store upgrades [39] Investment Themes - Investment Theme 1: Focus on high-end gold and fashion jewelry brands, recommending Chaohongji and Laopu Gold [6][37] - Investment Theme 2: Emphasize retail companies adapting to trends and AI-enabled cross-border e-commerce leaders, recommending Yonghui Supermarket and Aiyingshi [6][37] - Investment Theme 3: Highlight domestic beauty brands that meet emotional value and safety innovation, recommending Maogeping and Pola [6][37] - Investment Theme 4: Focus on differentiated medical beauty product manufacturers and leading medical beauty institutions, recommending Meilitiantian Medical Health and Aimeike [6][37]

Core Viewpoint - The personal care products sector experienced a decline of 1.72% on January 15, with a notable drop in the stock of Wanjian Medical, while the overall market showed mixed results with the Shanghai Composite Index down 0.33% and the Shenzhen Component Index up 0.41% [1] Group 1: Market Performance - The personal care products sector's decline was led by Wanjian Medical, which fell by 3.57% to a closing price of 38.08 [2] - The Shanghai Composite Index closed at 4112.6, down 0.33%, while the Shenzhen Component Index closed at 14306.73, up 0.41% [1] Group 2: Individual Stock Performance - Notable stock performances included: - Dengkang Oral (001328) rose by 2.51% to 41.27 with a trading volume of 28,300 shares and a transaction value of 116 million [1] - Other stocks such as Zhongshun Jierou (002511) and Liangmian Needle (600249) saw minor declines of 0.24% and 0.51% respectively [1] - The largest decline was observed in Wanjian Medical (300888), which dropped by 3.57% [2] Group 3: Capital Flow - The personal care products sector saw a net inflow of 531,700 yuan from institutional investors, while retail investors experienced a net outflow of 2,407,430 yuan [2] - The capital flow for individual stocks indicated that Wanjian Medical had a net inflow of 21,931,300 yuan from institutional investors, but a significant outflow of 45,204,800 yuan from retail investors [3]

Core Viewpoint - The personal care products sector experienced a slight increase of 0.2% on January 14, with Baiya Co., Ltd. leading the gains, while the Shanghai Composite Index fell by 0.31% and the Shenzhen Component Index rose by 0.56% [1]. Group 1: Market Performance - The closing price of Baiya Co., Ltd. was 21.24, with an increase of 1.09% and a trading volume of 77,000 shares, amounting to a transaction value of 163 million yuan [1]. - Other notable performers included Yiyi Co., Ltd. with a closing price of 28.72 and a rise of 1.06%, and Haoyue Care with a closing price of 32.78 and an increase of 1.02% [1]. - Conversely, companies like Jiya Co., Ltd. and Wanjian Medical saw slight declines of 0.19% and 0.23%, respectively [1]. Group 2: Capital Flow - The personal care products sector saw a net inflow of 4.32 million yuan from institutional investors, while retail investors experienced a net outflow of 7.12 million yuan [2]. - The capital flow data indicates that Yiyi Co., Ltd. had a significant net inflow of 13.31 million yuan from institutional investors, while it faced a net outflow of 6.19 million yuan from retail investors [3]. - Other companies like Haoyue Care and Dongkang Oral also showed mixed capital flows, with institutional inflows but retail outflows [3].

Core Viewpoint - The company, Runben Biotechnology Co., Ltd., has successfully passed the re-certification as a high-tech enterprise, which will allow it to continue enjoying tax benefits for the next three years [1]. Group 1: Certification Details - The company received its high-tech enterprise certification from the National High-tech Enterprise Recognition Management Work Leading Group Office, with certificate number GR202544006259, issued on December 19, 2025, and valid for three years [1]. - This re-certification follows the expiration of the company's previous high-tech enterprise certificate [1]. Group 2: Tax Benefits - As a result of the high-tech enterprise recognition, the company will benefit from a reduced corporate income tax rate of 15% for three consecutive years, from 2025 to 2027 [1]. Group 3: Implications for the Company - The recognition as a high-tech enterprise is a significant affirmation of the company's technological innovation and independent research and development capabilities [1]. - This status is expected to enhance the company's overall competitiveness and support its sustainable development [1].

Group 1 - The company, Runben Co., has recently been recognized as a high-tech enterprise by the National High-tech Enterprise Recognition Management Work Leading Group Office [2] - The certificate number for the high-tech enterprise recognition is GR202544006259, with an issuance date of December 19, 2025, and a validity period of three years [2] - This recognition is a re-evaluation following the expiration of the company's previous high-tech enterprise certificate [2]